Long-Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation

Long-Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation

At present, hematopoietic stem cell transplantation is the only curative treatment for β thalassemic patients. Conventional myeloablative stem cell transplantation is associated with significant morbidity and mortality, and non-myeloablative stem cell transplantation is associated with high graft fa...

Full description

Bibliographic Details
Main Authors: Mohammad Mahdi Adib Sereshki, Babak Bahar, Ardeshir Ghavamzadeh, Seyed Asadollah Mousavi, Kamran Alimoghaddam
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-04-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
β-thalassemia; Stem cell, Transplantation, Non-myeloablative, Fludarabine
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1062

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1062

Similar Items